Gamma-Delta (γδ) T Cell Therapy Combined With Checkpoint Inhibition Shows Potential Synergies in Vitro for Treatment of Glioblastoma
November 15, 2018 07:00 ET
|
Incysus Therapeutics, Inc.
Promising data from gamma-delta (γδ) T cell therapy in combination with checkpoint inhibitors to be presented at 2018 Society for Neuro-Oncology annual meeting NEW YORK, Nov. 15, 2018 (GLOBE...
Incysus Therapeutics to Participate in Panel at the 2018 Life Sciences Summit
October 22, 2018 08:00 ET
|
Incysus Therapeutics, Inc.
Panel Title: “Therapeutic Insight: Immuno-Oncology’s Next Generation Therapies” NEW YORK, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company...